Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & CEO

SVP, GM of BayMedica LLC

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. The company's prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. Its lead product is INM-755, a cannabinol topical skin cream, which is in Phase 2 clinical trial for the treatment of epidermolysis bullosa. The company is also developing INM-088, which is in preclinical studies for the treatment of glaucoma; INM-405 for the treatment of pain; and cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. In addition, it offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-21	Premium	bought	Premium	Premium	Premium	-
2024-02-20	Premium	bought	Premium	Premium	Premium	President & CEO
2022-04-14	Premium	bought	Premium	Premium	Premium	President & CEO
2022-04-13	Premium	bought	Premium	Premium	Premium	President & CEO
2022-01-24	Premium	bought	Premium	Premium	Premium	CFO
2022-01-06	Premium	bought	Premium	Premium	Premium	SVP, GM of BayMedica LLC
2021-12-30	Premium	bought	Premium	Premium	Premium	SVP, GM of BayMedica LLC
2021-11-15	Premium	bought	Premium	Premium	Premium	SVP, GM of BayMedica LLC
2021-09-29	Premium	bought	Premium	Premium	Premium	President & CEO
2021-09-28	Premium	bought	Premium	Premium	Premium	CFO
2021-09-28	Premium	bought	Premium	Premium	Premium	President & CEO

INM - InMed Pharmaceuticals Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for INM